SCHEMBL22420344

SCHEMBL22420344

CCCOCc1ccc(C(O)c2ccc(OC)c(OCCC)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.46
FDPS P14324 3/20 0.40
PDE4B Q07343 1/20 0.40
PPARG P37231 1/20 0.40
PPARD Q03181 1/20 0.40
PPARA Q07869 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
SLC22A1 O15245 1/20 0.39
ADRB2 P07550 1/20 0.39
CHRM2 P08172 1/20 0.39
ADRB1 P08588 1/20 0.39
CYP3A4 P08684 1/20 0.39
CHRM1 P11229 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
SLC6A4 P31645 1/20 0.39
OPRM1 P35372 1/20 0.39
SLC6A3 Q01959 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22420250 0.93 ALOX5 (0.51) ALOX5FDPSPPARGPPARDPPARA
SCHEMBL22420272 0.91 ALOX5 (0.43) ALOX5FDPSPPARGPPARDPPARA
SCHEMBL22420299 0.90 MAPK1 (0.46) ALOX5ALDH1A1LMNAKMT2ASIGMAR1
SCHEMBL30518790 0.86 ALOX5 (0.49) ALOX5PPARGPPARDPPARANPSR1
SCHEMBL18209343 0.86 ALOX5 (0.49) ALOX5PPARGPPARDPPARANPSR1
SCHEMBL22420316 0.82 ALOX5 (0.53) ALOX5PPARGPPARDPPARANPSR1
SCHEMBL22420269 0.81 SIGMAR1 (0.41) PDE4BALDH1A1KMT2ASIGMAR1
SCHEMBL22420252 0.81 LMNA (0.46) NPSR1ALDH1A1LMNAKMT2A
SCHEMBL10080328 0.81 SMPD1 (0.48) FDPSPDE4BPPARGPPARDPPARA
SCHEMBL22420314 0.77 C5AR1 (0.44) ALDH1A1KMT2APDE4ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10772858-B2 Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2020-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10772858-B2 Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors HIF1A, HIF1AN, EGLN2 ALOX5 1257/4885FDPS 962/4885PDE4B 1103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.